Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. (Q44638849)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 December 2009

Language	Label	Description	Also known as
English	Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.	scientific article published on 27 December 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

Friedo W. Dekker

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Enrico Eugenio Verrina

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Dimitrios J Tsakiris

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Vianda S Stel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Patrik Finne

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Emily Fraser

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

James Heaf

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Johan de Meester

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sabine Schmaldienst

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Kitty J Jager

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

0 references

publication date

27 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

number of pages

7

1 reference

based on heuristic

inferred from page(s)

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1200-1206

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20037169%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Multiple myeloma.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

Multiple myeloma and renal failure

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

The role of continuous ambulatory peritoneal dialysis in end-stage renal failure due to multiple myeloma

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

Multiple myeloma in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFP679

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44638849&oldid=1765782849"